Perinatal HIV Transmission: How Infants Acquire HIV and How to Prevent It

Transmission Routes

  • In utero: Transplacental (microtransfusions, chorioamnionitis) — ~20–30% of transmissions.
  • Intrapartum: Exposure to maternal blood/vaginal secretions during delivery — ~50–70%.
  • Postpartum: Breastfeeding — ~10–20% (if no ART).

Risk Without Intervention

15–45% transmission rate (higher with high VL, low CD4, prolonged rupture of membranes, breastfeeding).

Prevention Strategy (WHO/CDC) — >99% Effective

  1. Maternal ART: Start ASAP; goal VL <50 copies/mL by delivery. Preferred: DTG + TDF/FTC (or TAF/FTC).
  2. Intrapartum IV ZDV: If VL >1000 or unknown near delivery.
  3. Elective C-section at 38 weeks: If VL >1000 at 36–38 wks.
  4. Infant Prophylaxis: ZDV 4–6 weeks (low risk) or multi-drug (high risk).
  5. Formula feeding: Avoid breastfeeding in resource-rich settings (U.S. guideline). In resource-limited: maternal ART + infant prophylaxis + exclusive breastfeeding 6 mo + rapid wean.
  6. Infant Testing: HIV DNA/RNA PCR at birth, 2–4 wks, 4–6 wks, 4–6 mo. Definitive exclusion: 2 negative virologic tests (1 ≥1 mo, 1 ≥4 mo) or 2 negative antibody tests ≥6 mo (no breastfeeding).

Current U.S. Statistics

<100 perinatal infections/year (down from ~1,700 in 1990s). Elimination is feasible.

HIV & AIDS - Related Articles